SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization.
SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization.
复制标题
DOI:
10.1172/jci.insight.148135
复制
发表时间:
2021-11-08
期刊:
影响因子:
8
通讯作者:
Harada H
中科院分区:
文献类型:
--
作者:
Suwa T;Kobayashi M;Shirai Y;Nam JM;Tabuchi Y;Takeda N;Akamatsu S;Ogawa O;Mizowaki T;Hammond EM;Harada H
Hypoxia is associated with tumor radioresistance; therefore, a predictive marker for tumor hypoxia and a rational target to overcome it have been sought to realize personalized radiotherapy. Here, we show that serine protease inhibitor Kazal type I (SPINK1) meets these 2 criteria. SPINK1 expression was induced upon hypoxia (O2 < 0.1%) at the transcription initiation level in a HIF-dependent manner, causing an increase in secreted SPINK1 levels. SPINK1 proteins were detected both within and around hypoxic regions of xenografted and clinical tumor tissues, and their plasma levels increased in response to decreased oxygen supply to xenografts. Secreted SPINK1 proteins enhanced radioresistance of cancer cells even under normoxic conditions in EGFR-dependent and nuclear factor erythroid 2–related factor 2–dependent (Nrf2-dependent) manners and accelerated tumor growth after radiotherapy. An anti-SPINK1 neutralizing antibody exhibited a radiosensitizing effect. These results suggest that SPINK1 secreted from hypoxic cells protects the surrounding and relatively oxygenated cancer cells from radiation in a paracrine manner, justifying the use of SPINK1 as a target for radiosensitization and a plasma marker for predicting tumor hypoxia.
登录
查看更多内容
影响因子:
3.9
作者:
SCHEVING, LA
通讯作者:
SCHEVING, LA
影响因子:
5.9
作者:
Masson N;Ratcliffe PJ
通讯作者:
Ratcliffe PJ
影响因子:
11.1
作者:
Soon, Wendy WeiJia;Miller, Lance David;Black, Michael A.;Dalmasso, Cyril;Chan, Xiu Bin;Pang, Brendan;Ong, Chee Wee;Salto-Tellez, Manuel;Desai, Kartiki V.;Liu, Edison T.
通讯作者:
Liu, Edison T.
影响因子:
5.7
作者:
Koyasu S;Kobayashi M;Goto Y;Hiraoka M;Harada H
通讯作者:
Harada H
影响因子:
17.1
作者:
Ateeq B;Tomlins SA;Laxman B;Asangani IA;Cao Q;Cao X;Li Y;Wang X;Feng FY;Pienta KJ;Varambally S;Chinnaiyan AM
通讯作者:
Chinnaiyan AM